Par Pharmaceutical Companies, Inc.’s (PRX) share price has entered into oversold territory with a stochastic value of 17.24. The Zacks Consensus Estimate on the company’s earnings for December 2010 increased by 3 cents over the past week to $3.01 cents per share. Par Pharmaceutical Companies, Inc. is a Zacks #1 Rank (“Strong Buy”) company.
 
PAR PHARMA COS (PRX): Free Stock Analysis Report
 
Zacks Investment Research